Latest News of BBIO
BridgeBio Pharma (BBIO) Is Up 13.0% After Positive Phase 3 BBP-418 Results in Muscular Dystrophy
By Yahoo! Finance | 1 week ago
UBS Reaffirms Buy on BridgeBio (BBIO) With Optimism Around Attruby Launch
By Yahoo! Finance | 1 month ago
BridgeBio Pharma, Inc. (BBIO) Retains $68 Target on Strong Launch Dynamics
By Yahoo! Finance | 1 month ago